Special Feature on Development of Therapeutic Antibodies and Next Generation Protein Drugs
Currently, there are more than 58 antibodies clinically available for the treatment of various diseases including cancer, chronic inflammation, and infection. In 2016, eight antibodies were newly approved, and the annual number of antibodies approved has been increasing for the past decade. This special feature of Experimental & Molecular Medicine presents reviews and original articles focusing on therapeutic antibodies and biopharmaceuticals.
